SCHEMBL20249683

SCHEMBL20249683

Cc1c2c(-c3cccnc3)nc3cc(-c4cc(-c5ccccn5)cc(-c5ccccn5)c4)ccc3c2c(C)c2c(-c3cccnc3)nc3ccccc3c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.45
DHODH Q02127 3/20 0.39
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
NPC1 O15118 3/20 0.38
CYP19A1 P11511 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GBA1 P04062 1/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
CLK4 Q9HAZ1 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20245248 0.91 DHODH (0.43) DHODHNPC1KDM4ETSHRPKM
SCHEMBL20249666 0.91 DHODH (0.43) CYP2A6DHODHPIM1CYP19A1TSHR
SCHEMBL20249640 0.91 DHODH (0.39) CYP2A6DHODHNPC1KDM4ETSHR
SCHEMBL20245064 0.89 DHODH (0.43) CYP2A6DHODHPIM1CYP19A1TSHR
SCHEMBL20249680 0.88 DHODH (0.41) DHODHCYP19A1TSHRSMN1; SMN2GBA1
SCHEMBL20249634 0.87 DHODH (0.43) CYP2A6DHODHPIM1CYP19A1KDM4E
SCHEMBL20245040 0.87 DHODH (0.45) DHODHNPC1KDM4ETSHRRAB9A
SCHEMBL20249648 0.87 KDM4E (0.44) DHODHNPC1KDM4ETSHRHSD17B10
SCHEMBL20249651 0.87 DHODH (0.44) CYP2A6DHODHPIM1CYP19A1TSHR
SCHEMBL20245038 0.86 DHODH (0.46) CYP2A6DHODHPIM1CYP19A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP2A6 2019/4885DHODH 1907/4885PIM1 2681/4885
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP2A6 2019/4885DHODH 1907/4885PIM1 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.